BCRX — BioCryst Pharmaceuticals Inc · rev $874.8M

BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.

Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. BCRX currently screens at market cap $1.83B.

Use this BCRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BCRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BCRX SEC filings page. Lician reads the product cache first so this HTML stays unique to BioCryst Pharmaceuticals Inc even when a live quote feed is slow.

BioCryst Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full BCRX income, balance, and cash tables.

  • Revenue$874.8M
  • Net Income$263.9M
  • Total Assets$514.2M
  • Total Debt$0
  • Free Cash Flow$344.9M

BCRX recent filings